Bioinspired negatively charged calcium phosphate nanocarriers for cardiac delivery of MicroRNAs

Nanomedicine

Volumn 11, Issue 8, 2016, Pages 891-906

  Di Mauro, Vittoria ^a,b   Iafisco, Michele ^c   Salvarani, Nicolò ^a,b   Vacchiano, Marco ^a   Carullo, Pierluigi ^a,b   Ramírez Rodríguez, Gloria Belén ^c   Patrício, Tatiana ^c   Tampieri, Anna ^c   Miragoli, Michele ^a,b   Catalucci, Daniele ^a,b  

^a Milan Unit   (Italy)

^b HUMANITAS CLINICAL AND RESEARCH CENTER   (Italy)

^c INSTITUTE OF SCIENCE AND TECHNOLOGY FOR CERAMICS   (Italy)

Author keywords

calcium phosphate nanoparticles; cardiomyocytes; drug delivery systems; microRNA; nanomedicine

Indexed keywords

CALCIUM; CALCIUM PHOSPHATE; CARBON; CITRATE SODIUM; CITRIC ACID; COPPER; MICRORNA; NANOCARRIER; OXYGEN; POLYVINYL ACETATE; BIOMATERIAL; DRUG CARRIER; NANOPARTICLE;

ADULT; ANIMAL EXPERIMENT; ARTICLE; BIOCOMPATIBILITY; BIOMINERALIZATION; CALCIUM CELL LEVEL; CENTRIFUGATION; CHEMICAL COMPOSITION; COMPARATIVE STUDY; CONFOCAL MICROSCOPY; CONTROLLED STUDY; CRYSTALLIZATION; EXCITATION CONTRACTION COUPLING; FREEZE DRYING; GENE DELIVERY SYSTEM; HEART MUSCLE CELL; IN VITRO STUDY; IN VIVO STUDY; INFRARED SPECTROSCOPY; INTERNALIZATION; INTRACELLULAR SPACE; ION CURRENT; LUCIFERASE ASSAY; MALE; MEMBRANE POTENTIAL; MOUSE; MUSCLE CONTRACTILITY; NANOENCAPSULATION; NONHUMAN; ONE POT SYNTHESIS; PARTICLE SIZE; PH; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SURFACE CHARGE; X RAY ANALYSIS; ANIMAL; C57BL MOUSE; CARDIAC MUSCLE CELL; CELL CULTURE; CELL LINE; CHEMISTRY; DRUG DELIVERY SYSTEM; GENE TRANSFER; HUMAN; METABOLISM;

ANIMALS; BIOCOMPATIBLE MATERIALS; CALCIUM PHOSPHATES; CELL LINE; CELLS, CULTURED; DRUG CARRIERS; DRUG DELIVERY SYSTEMS; GENE TRANSFER TECHNIQUES; HUMANS; MICE, INBRED C57BL; MICRORNAS; MYOCYTES, CARDIAC; NANOPARTICLES;

EID: 84962198324     PISSN: 17435889     EISSN: 17486963     Source Type: Journal    
DOI: 10.2217/nnm.16.26     Document Type: Article

References (56)

1. WHO. Cardiovascular diseases. www.who.int/cardiovascular-diseases/en/
2. Mosterd A, Hoes AW. Clinical epidemiology of heart failure. Heart 93 (9), 1137-1146 (2007).
3. Olson EN. MicroRNAs as therapeutic targets and biomarkers of cardiovascular disease. Sci. Transl. Med. 6(239), 239ps233 (2014).
4. Romaine SP, Tomaszewski M, Condorelli G, Samani NJ. MicroRNAs in cardiovascular disease: an introduction for clinicians. Heart 101(12), 921-928 (2015).
5. Poller W, Hajjar R, Schultheiss HP, Fechner H. Cardiac-targeted delivery of regulatory RNA molecules and genes for the treatment of heart failure. Cardiovasc. Res. 86(3), 353-364 (2010).
6. Eulalio A, Mano M, Dal Ferro M et al. Functional screening identifes miRNAs inducing cardiac regeneration. Nature 492(7429), 376-381 (2012).
7. Quattrocelli M, Crippa S, Montecchiani C et al. Long-term miR-669a therapy alleviates chronic dilated cardiomyopathy in dystrophic mice. J. Am. Heart Assoc. 2(4), e000284 (2013).
8. Fitzgerald K T, Holladay CA, Mccarthy C, Power KA, Pandit A, Gallagher WM. Standardization of models and methods used to assess nanoparticles in cardiovascular applications. Small 7(6), 705-717 (2011).
9. Matoba T, Egashira K. Nanoparticle-mediated drug delivery system for cardiovascular disease. Int. Heart J. 55 (4), 281-286 (2014).
10. Suarez S, Almutairi A, Christman KL. Micro-and nanoparticles for treating cardiovascular disease. Biomater. Sci. 3(4), 564-580 (2015).
11. Chang MY, Yang YJ, Chang CH et al. Functionalized nanoparticles provide early cardioprotection after acute myocardial infarction. J. Control. Release 170(2), 287-294 (2013).
12. Gray WD, Che P, Brown M, Ning X, Murthy N, Davis ME. N-acetylglucosamine conjugated to nanoparticles enhances myocyte uptake and improves delivery of a small molecule p38 inhibitor for post-infarct healing. J. Cardiovasc. Transl. Res. 4(5), 631-643 (2011).
13. Verma DD, Hartner WC, Levchenko TS, Bernstein EA, Torchilin V P. ATP-loaded liposomes effectively protect the myocardium in rabbits with an acute experimental myocardial infarction. Pharm. Res. 22(12), 2115-2120 (2005).
14. Canyon SJ, Dobson GP. Protection against ventricular arrhythmias and cardiac death using adenosine and lidocaine during regional ischemia in the in vivo rat. Am. J. Physiol. Heart C 287(3), H1286-H1295 (2004).
15. Liu M, Li M, Wang G et al. Heart-targeted nanoscale drug delivery systems. J. Biomed. Nanotechnol. 10(9), 2038-2062 (2014).
16. Thakor AS, Gambhir SS. Nanooncology: the future of cancer diagnosis and therapy. CA Cancer J. Clin. 63(6), 395-418 (2013).
17. Eloy JO, Claro De Souza M, Petrilli R, Barcellos JP, Lee RJ, Marchetti JM. Liposomes as carriers of hydrophilic small molecule drugs: strategies to enhance encapsulation and delivery. Colloids Surf. B. Biointerfaces 123, 345-363 (2014).
18. Kobayashi K, Wei JJ, Iida R, Ijiro K, Niikura K. Surface engineering of nanoparticles for therapeutic applications. Polym. J. 46(8), 460-468 (2014).
19. Miragoli M, Novak P, Ruenraroengsak P et al. Functional interaction between charged nanoparticles and cardiac tissue: a new paradigm for cardiac arrhythmia? Nanomedicine (Lond.) 8(5), 725-737 (2013).
20. Claycomb WC, Lanson NA Jr, Stallworth BS et al. HL-1 cells: a cardiac muscle cell line that contracts and retains phenotypic characteristics of the adult cardiomyocyte. Proc. Natl Acad. Sci. USA 95(6), 2979-2984 (1998).
21. 2+ channel activity by modulating Cavalpha1 protein stability. J. Cell Biol. 184(6), 923-933 (2009).
22. Castaldi A, Zaglia T, Di Mauro V et al. MicroRNA-133 modulates the beta1-adrenergic receptor transduction cascade. Circ. Res. 115(2), 273-283 (2014).
23. Bang C, Batkai S, Dangwal S et al. Cardiac fbroblast-derived microRNA passenger strand-enriched exosomes mediate cardiomyocyte hypertrophy. J. Clin. Invest. 124(5), 2136-2146 (2014).
24. Beniash E. Biominerals-hierarchical nanocomposites: the example of bone. Wiley Interdiscip. Rev. Nanomed. Nanobiotechnol. 3(1), 47-69 (2011).
25. Morgan TT, Muddana HS, Altinoglu EI et al. Encapsulation of organic molecules in calcium phosphate nanocomposite particles for intracellular imaging and drug delivery. Nano Lett. 8(12), 4108-4115 (2008).
26. Iafsco M, Palazzo B, Martra G et al. Nanocrystalline carbonate-apatites: role of Ca/P ratio on the upload and release of anticancer platinum bisphosphonates. Nanoscale 4(1), 206-217 (2012).
27. Iafsco M, Delgado-Lopez JM, Varoni EM et al. Cell surface receptor targeted biomimetic apatite nanocrystals for cancer therapy. Small 9(22), 3834-3844 (2013).
28. Rodriguez-Ruiz I, Delgado-Lopez JM, Duran-Olivencia MA et al. pH-responsive delivery of doxorubicin from citrate-apatite nanocrystals with tailored carbonate content. Langmuir 29(26), 8213-8221 (2013).
29. Li D, He J, Huang X et al. Intracellular pH-responsive mesoporous hydroxyapatite nanoparticles for targeted release of anticancer drug. RSC Adv. 5(39), 30920-30928 (2015).
30. Lacerda L, Bianco A, Prato M, Kostarelos K. Carbon nanotubes as nanomedicines: from toxicology to pharmacology. Adv. Drug Deliv. Rev. 58 (14), 1460-1470 (2006).
31. Delgado-López JM, Frison R, Cervellino A, Gómez-Morales J, Guagliardi A, Masciocchi N. Crystal size, morphology, and growth mechanism in bio-inspired apatite nanocrystals. Adv. Funct. Mater. 24(8), 1090-1099 (2014).
32. Davies E, Muller KH, Wong WC et al. Citrate bridges between mineral platelets in bone. Proc. Natl Acad. Sci. USA 111(14), E1354-E1363 (2014).
33. Delgado-Lopez JM, Iafsco M, Rodriguez I, Tampieri A, Prat M, Gomez-Morales J. Crystallization of bioinspired citrate-functionalized nanoapatite with tailored carbonate content. Acta Biomater. 8(9), 3491-3499 (2012).
34. Termine JD, Posner AS. Infra-red determinaion of the percentage of crystallinity in apatitic calcium phosphates. Nature 211(5046), 268-270 (1966).
35. Novak P, Shevchuk A, Ruenraroengsak P et al. Imaging single nanoparticle interactions with human lung cells using fast ion conductance microscopy. Nano Lett. 14 (3), 1202-1207 (2014).
36. Spindler AJ, Noble SJ, Noble D. Comparison of step and ramp voltage clamp on background currents in guinea-pig ventricular cells. Exp. Physiol. 84(5), 865-879 (1999).
37. Bers DM. Cardiac excitation-contraction coupling. Nature 415(6868), 198-205 (2002).
38. Doane TL, Burda C. The unique role of nanoparticles in nanomedicine: imaging, drug delivery and therapy. Chem. Soc. Rev. 41(7), 2885-2911 (2012).
39. Roveri N, Palazzo B, Iafsco M. The role of biomimetism in developing nanostructured inorganic matrices for drug delivery. Expert Opin. Drug Deliv. 5(8), 861-877 (2008).
40. Singh N, Jenkins GJ, Asadi R, Doak SH. Potential toxicity of superparamagnetic iron oxide nanoparticles (SPION). Nano Rev. 1, doi:10.3402/nano.v1i0.5358 (2010).
41. Jung H, Kim SA, Yang YG, Yoo H, Lim SJ, Mok H. Long chain microRNA conjugates in calcium phosphate nanoparticles for effcient formulation and delivery. Arch. Pharm. Res. 38 (5), 705-715 (2015).
42. Xie Y, Chen Y, Sun M, Ping Q. A mini review of biodegradable calcium phosphate nanoparticles for gene delivery. Curr. Pharm. Biotechnol. 14(10), 918-925 (2013).
43. Kakizawa Y, Kataoka K. Block copolymer self-assembly into monodispersive nanoparticles with hybrid core of antisense DNA and calcium phosphate. Langmuir 18(12), 4539-4543 (2002).
44. Kakizawa Y, Furukawa S, Ishii A, Kataoka K. Organic-inorganic hybrid-nanocarrier of siRNA constructing through the self-assembly of calcium phosphate and PEG-based block aniomer. J. Control. Release 111(3), 368-370 (2006).
45. Devarasu T, Saad R, Ouadi A et al. Potent calcium phosphate nanoparticle surface coating for in vitro and in vivo siRNA delivery: a step toward multifunctional nanovectors. J. Mater. Chem. B 1(36), 4692-4700 (2013).
46. Vilar G, Tulla-Puche J, Albericio F. Polymers and drug delivery systems. Curr. Drug Deliv. 9(4), 367-394 (2012).
47. Moghimi SM, Symonds P, Murray JC, Hunter AC, Debska G, Szewczyk A. A two-stage poly(ethylenimine)-mediated cytotoxicity: implications for gene transfer/therapy. Mol. Ther. 11(6), 990-995 (2005).
48. Hu YY, Rawal A, Schmidt-Rohr K. Strongly bound citrate stabilizes the apatite nanocrystals in bone. Proc. Natl Acad. Sci. USA 107(52), 22425-22429 (2010).
49. Banik M, Basu T. Calcium phosphate nanoparticles: a study of their synthesis, characterization and mode of interaction with salmon testis DNA. Dalton Trans. 43(8), 3244-3259 (2014).
50. Li J, Chen YC, Tseng YC, Mozumdar S, Huang L. Biodegradable calcium phosphate nanoparticle with lipid coating for systemic siRNA delivery. J. Control. Release 142 (3), 416-421 (2010).
51. Banik M, Mukherjee R, Patra M et al. Spectrofuorimetric study on in vitro interaction between calcium phosphate nanoparticle and salmon testis DNA. J. Nanopart. Res. 16(1), 1-11 (2013).
52. Savi M, Rossi S, Bocchi L et al. Titanium dioxide nanoparticles promote arrhythmias via a direct interaction with rat cardiac tissue. Part. Fibre Toxicol. 11, 63 (2014).
53. Olton DY, Close JM, Sfeir CS, Kumta PN. Intracellular traffcking pathways involved in the gene transfer of nano-structured calcium phosphate-DNA particles. Biomaterials 32(30), 7662-7670 (2011).
54. Maguy A, Hebert TE, Nattel S. Involvement of lipid rafts and caveolae in cardiac ion channel function. Cardiovasc. Res. 69(4), 798-807 (2006).
55. Nichols B. Caveosomes and endocytosis of lipid rafts. J. Cell Sci. 116(Pt 23), 4707-4714 (2003).
56. Dizaj SM, Jafari S, Khosroushahi AY. A sight on the current nanoparticle-based gene delivery vectors. Nanoscale Res. Lett. 9(1), 252 (2014).